US2004083001A1PendingUtilityA1
Intervertebral disc
Priority: Jun 29, 2000Filed: Jun 29, 2001Published: Apr 29, 2004
Est. expiryJun 29, 2020(expired)· nominal 20-yr term from priority
Inventors:Rita Kandel
A61P 17/00A61F 2002/30677A61F 2/28A61F 2310/00359A61L 27/3817A61L 27/3633A61L 27/3612A61L 27/3856A61F 2002/445A61L 2430/38A61F 2002/4435A61F 2002/4445
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to an engineered biological material comprising or enriched for tissue of intervertebral disc; tissue derived from an engineered biological material; constructs comprising one or more tissues from an engineered biological material; methods for producing the engineered biological materials and constructs; and methods of using the engineered biological materials and constructs.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An engineered biological material comprising one or more tissues of intervertebral disc.
2 . An engineered biological material as claimed in claim 1 characterized by a continuous layer of nucleus pulposus tissue.
3 . An engineered biological material as claimed in claim 1 characterized by a continuous layer of annulus fibrosus tissue.
4 . An engineered biological material as claimed in claim 1 , 2 , or 3 further characterized by the presence of extracellular matrix, large proteoglycans and collagen.
5 . An engineered biological material as claimed in claim 2 or 4 wherein the continuous layer of nucleus pulposus tissue is on a substrate.
6 . An engineered biological material as claimed in claim 3 or 4 wherein the continuous layer of annulus fibrosus tissue is on a substrate.
7 . An engineered biological material as claimed in claim 5 or 6 wherein the substrate is selected from the group consisting of bone, an engineered biomaterial, preferably an engineered bone substitute, and porous tissue culture inserts.
8 . Nucleus pulposus tissue obtained from an engineered biological material of claim 2 or 5 .
9 . Annulus fibrosus tissue obtained from an engineered biological material of claim 3 or 6 .
10 . An intervertebral disc construct comprising nucleus pulposus tissue as claimed in claim 8 or annulus fibrosus tissue as claimed in claim 9 fused to a substrate.
11 . An intervertebral disc construct comprising nucleus pulposus tissue as claimed in claim 8 fused to a continuous layer of cartilage tissue on a substrate.
12 . An intervertebral disc construct as claimed in claim 11 wherein the nucleus pulposus tissue is surrounded by a continuous layer of annulus fibrosus tissue.
13 . A process for producing an engineered biological material as claimed in claim 1 comprising:
(a) isolating nucleus pulposus cells or annulus fibrosus cells from intervertebral disc;
(b) forming a layer of the nucleus pulposus cells or annulus fibrosus cells on a substrate, and;
(c) culturing the nucleus pulposus cells or annulus fibrosus cells in growth media under suitable conditions so that the nucleus pulposus cells or annulus fibrosus cells accumulate extracellular matrix and form a continuous layer of nucleus pulposus tissue or annulus fibrosus tissue.
14 . A process for producing an engineered biological material as claimed in claim 1 comprising:
(a) isolating nucleus pulposus cells and annulus fibrosus cells from intervertebral disc;
(b) forming a layer of the nucleus pulposus cells surrounded by the annulus fibrosus cells on a substrate; and
(c) culturing the nucleus pulposus cells and annulus fibrosus cells in growth media under suitable conditions so that the nucleus pulposus cells and annulus fibrosus cells accumulate extracellular matrix and form nucleus pulposus tissue surrounded by annulus fibrosus tissue.
15 . A process as claimed in claim 13 or 14 wherein the substrate is selected from the group consisting of bone, an engineered biomaterial preferably an engineered bone substitute, and porous tissue culture inserts.
16 . An engineered biological material or intervertebral disc construct as claimed in any preceding claim wherein cells of the nucleus pulposus tissue or annulus fibrosus tissue are transformed with recombinant vectors containing an exogenous gene encoding a biologically active protein that corrects or compensates for a genetic deficiency, or stimulates cell growth or stimulates extracellular matrix production by cells, or encodes a drug.
17 . A system for testing a substance that affects nucleus pulposus cells or annulus fibrosus cells comprising:
(a) generating or culturing an engineered biological material, or construct as claimed in any preceding claim in the presence of a substance which is suspected of affecting nucleus pulposus tissue or annulus fibrous tissue; and (b) determining the biochemical composition and/or physiological organization of tissue generated or cultured with the biochemical composition and/or physiological organization of the biological material or construct generated or cultured in the absence of the substance.
18 . A method of using an engineered biological material or construct as claimed in any preceding claim to test pharmaceutical preparations for efficacy in the treatment of diseases of intervertebral disc.
19 . A method of replacing or repairing damaged or deficient intervertebral discs or portions thereof of a patient comprising implanting an engineered biological material, nucleus pulposus tissue, annulus fibrosus tissue, or construct as claimed in any preceding claim into the site of the damaged or deficient intervertebral disc or portions thereof, of the patient.
20 . A method for enhancing healing of an intervertebral disc in a patient which comprises inserting an engineered biological material, nucleus pulposus tissue, annulus fibrosus tissue, or construct as claimed in any preceding claim into the site of a damaged intervertebral disc.
21 . A method for repairing damaged or degenerated intervertebral discs comprising evacuating tissue from a nucleus pulposus portion of a degenerated intervertebral disc space, preparing an engineered biological material in accordance with a process as claimed in claim 13 using nucleus pulposus cells from the evacuated tissue, and implanting the engineered biological material in the space where the tissue was evacuated.
22 . A method for investigating the metabolism or degeneration of nucleus pulposus or annulus fibrosus cells or tissue using an engineered biological material or construct as claimed in any preceding claim as an in vitro model.
23 . A gene therapy method comprising using an engineered biological material or construct as claimed in any preceding claim.
24 . Use of an engineered biological material, nucleus pulposus tissue, annulus fibrosus tissue, or construct as claimed in any preceding claim as an implant to replace or repair damaged or deficient intervertebral disc.Join the waitlist — get patent alerts
Track US2004083001A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.